Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Arthritis therapeutics Market Research Reports

Titlepublishedprice

Global Arthritis Partnering 2010 to 2017

By Current Partnering
"...... he Global Arthritis Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • ......"
01-Feb-2017$1495

Global Rheumatoid Arthritis Partnering 2010 to 2017

By Current Partnering
"...... The Global Rheumatoid Arthritis Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering dea......"
01-Feb-2017$1495

Global Osteoarthritis Partnering 2010 to 2017

By Current Partnering
"...... /> The Global Osteoarthritis Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals......"
01-Feb-2017$1495

Juvenile Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... Report is to understand the market and pipeline status of the drugs around the Juvenile Arthritis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveI......"
01-Jan-2017$2000

Gouty Arthritis (Gout)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... (Gout) Report is to understand the market and pipeline status of the drugs around the Gouty Arthritis (Gout) to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies......"
01-Jan-2017$2000

Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... Rheumatoid Arthritis Report is to understand the market and pipeline status of the drugs around the Juvenile Rheumatoid Arthritis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designin......"
01-Jan-2017$2000

Joint Pain-Pipeline Insights, 2017

By Delve Insight
"...... I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. D......"
01-Jan-2017$1250

EpiCast Report: Systemic Lupus Erythematosus (SLE) - Epidemiology Forecast to 2025

By GlobalData
"...... anifestations ranging from dermatological involvement to multi-organ failure with episodes of relapses and remissions. Because of its dynamic nature, this disease has an unpredictable natural course leading to high rates of morbidity and even death. ......"
01-Jan-2017$3995

Juvenile Rheumatoid Arthritis-Pipeline Insights, 2017

By Delve Insight
"...... g Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent a......"
01-Jan-2017$1250

Osteoarthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... s to understand the market and pipeline status of the drugs around the Osteoarthritis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Rep......"
01-Jan-2017$2000

Avail upto 50% Discount on below Publisher Reports.